Claros | $30,000,000 | (Mar 20, 2026)
Corridor | $25,000,000 | (Mar 20, 2026) Certified by Founder
Lodge
Trogenix
start up
United Kingdom
- Edinburgh, Scotland
- 07/10/2025
- Series A
- $94,323,600
Precision genetic medicines, engineered for change
- Industry Biotechnology Research
- Website https://trogenix.com/
- LinkedIn https://www.linkedin.com/company/trogenixbio/
Related People
Ken MacnamaraFounder
United Kingdom -
Greater Edinburgh Area
Ken is the Chief Executive Officer of Trogenix, a biotech uniting cutting-edge technologies in genomics, oncology, immunotherapy, and gene therapy to create a revolutionary therapeutic approach.
Avtal | $24,000,000 | (Mar 20, 2026)
RunSybil | $40,000,000 | (Mar 20, 2026)
Latent | $80,000,000 | (Mar 20, 2026)
PADO AI | $6,000,000 | (Mar 20, 2026)
SetSale | $2,000,000 | (Mar 19, 2026)
xmemory | $4,000,000 | (Mar 19, 2026)
Laminar (YC S24) | $3,000,000 | (Mar 19, 2026)
Obin AI | $7,000,000 | (Mar 19, 2026)
Multiply(US) | $9,500,000 | (Mar 19, 2026)